Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jun 14, 2023

BUY
$1.67 - $2.35 $8,794 - $12,375
5,266 New
5,266 $9.8 Million
Q4 2022

Mar 30, 2023

BUY
$1.67 - $2.35 $467 - $658
280 Added 5.62%
5,266 $9,000
Q4 2022

Feb 15, 2023

BUY
$1.67 - $2.35 $8,794 - $12,375
5,266 New
5,266 $9,000
Q2 2022

Aug 11, 2022

SELL
$1.34 - $5.34 $6,681 - $26,625
-4,986 Closed
0 $0
Q1 2022

Jun 20, 2023

BUY
$4.58 - $6.8 $22,835 - $33,904
4,986 New
4,986 $22,000
Q1 2022

Mar 30, 2023

SELL
$4.58 - $6.8 $37,230 - $55,277
-8,129 Reduced 61.98%
4,986 $22,000
Q1 2022

May 12, 2022

SELL
$4.58 - $6.8 $37,230 - $55,277
-8,129 Reduced 61.98%
4,986 $23,000
Q4 2021

Jun 21, 2023

BUY
$5.23 - $7.18 $68,591 - $94,165
13,115 New
13,115 $84,000
Q4 2021

Mar 30, 2023

BUY
$5.23 - $7.18 $17,232 - $23,658
3,295 Added 33.55%
13,115 $84,000
Q4 2021

Feb 15, 2022

BUY
$5.23 - $7.18 $17,232 - $23,658
3,295 Added 33.55%
13,115 $84,000
Q3 2021

Jun 21, 2023

BUY
$5.94 - $8.75 $58,330 - $85,925
9,820 New
9,820 $60,000
Q3 2021

Mar 30, 2023

SELL
$5.94 - $8.75 $47,098 - $69,378
-7,929 Reduced 44.67%
9,820 $60,000
Q3 2021

Nov 15, 2021

SELL
$5.94 - $8.75 $47,098 - $69,378
-7,929 Reduced 44.67%
9,820 $61,000
Q2 2021

Jun 21, 2023

BUY
$7.54 - $9.79 $133,827 - $173,762
17,749 New
17,749 $141,000
Q2 2021

Mar 30, 2023

BUY
$7.54 - $9.79 $13,768 - $17,876
1,826 Added 11.47%
17,749 $141,000
Q2 2021

Aug 16, 2021

BUY
$7.54 - $9.79 $133,706 - $173,606
17,733 Added 110831.25%
17,749 $142,000
Q1 2021

Jun 26, 2023

BUY
$4.76 - $11.25 $75,793 - $179,133
15,923 New
15,923 $153 Million
Q1 2021

Mar 30, 2023

BUY
$4.76 - $11.25 $50,727 - $119,891
10,657 Added 202.37%
15,923 $153,000
Q1 2021

May 14, 2021

BUY
$4.76 - $11.25 $76 - $180
16 New
16 $153,000
Q2 2018

Aug 15, 2018

SELL
$4.43 - $5.14 $75,832 - $87,986
-17,118 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$4.65 - $5.9 $79,598 - $100,996
17,118 New
17,118 $0
Q4 2017

Feb 15, 2018

SELL
$4.32 - $5.52 $152,677 - $195,087
-35,342 Closed
0 $0
Q3 2017

Nov 14, 2017

SELL
$4.35 - $5.25 $530 - $640
-122 Reduced 0.34%
35,342 $186,000
Q2 2017

Aug 14, 2017

BUY
N/A
35,464
35,464 $193,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.